The role of myocardial KATP-channel blockade in the protective effects of glibenclamide against ischaemia in the rat heart

Pharmacology and Toxicology

Volumn 91, Issue 2, 2002, Pages 51-56

  Legtenberg, Roger J ^a   Rongen, Gerard A ^a   Houston, Ralph J F ^a,b   Oeseburg, Berend ^a   Smits, Paul ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DIAZOXIDE; GLIBENCLAMIDE; PINACIDIL; POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG MECHANISM; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; ISOLATED HEART; MALE; MITOCHONDRIAL RESPIRATION; NONHUMAN; PRIORITY JOURNAL; RAT; STUNNED HEART MUSCLE; ANIMAL; DRUG EFFECT; DRUG INTERACTION; WISTAR RAT;

ANIMALIA;

ANIMALS; CORONARY CIRCULATION; DIAZOXIDE; DRUG INTERACTIONS; GLYBURIDE; MALE; MYOCARDIAL ISCHEMIA; PINACIDIL; POTASSIUM CHANNELS; RATS; RATS, WISTAR;

EID: 0036667724     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0773.2002.910202.x     Document Type: Article

References (38)

1. Improvement of cardiac function impaired by repeated ischemic arrests in isolated rat hearts
2. ATP-sensitive potassium channels and myocardial ischemia: Why do they open?
3. Effect of potassium on the action of the KATP modulators cromakalim, pinacidil, or glibenclamide on arrhythmias in isolated perfused rat heart subjected to regional ischaemia
4. Effects of cromakalim and glibenclamide on myocardial high energy phosphates and intracellular pH during ischemia-reperfusion: 31P NMR studies
5. Assessment of ischemic injury and protective interventions: The Langendorff versus the working rat heart preparation
6. Cation transport in mitochondria - The potassium cycle
7. Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection
8. Oral hypoglycernic agents
9. Sulfonylureas in NIDDM
10. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs
11. Protective effects of ATP-sensitive potassium-channel openers in experimental myocardial ischemia
12. The protective effects of cromakalim and pinacidil on reperfusion function and infarct size in isolated perfused rat hearts and anesthetized dogs
13. Mitochondrial ATP-sensitive K+ channels modulate cardiac mitochondrial function
14. Pharmacological and histochemical distinctions between molecularly defined sarcolemmal KATP channels and native cardiac mitochondrial KATP channels
15. Glibenclamide decreases basal coronary blood flow in anesthetized dogs
16. Effects of sulfonylurea derivatives on ischemia-induced loss of function in the isolated rat heart
17. Inhibitors of nitric oxide synthesis and ischemia/reperfusion attenuate coronary vasodilator response to pinacidil in isolated rat heart
18. Dinitrophenol, cyclosporin A, and trimetazidine modulate preconditioning in the isolated rat heart: Support for a mitochondrial role in cardioprotection
19. Attenuation of postischemic reperfusion injury is related to prevention of [Ca2+]m overload in rat hearts
20. Blockade of the KATP-channel by glibenclamide aggravates ischemic injury, and counteracts ischemic preconditioning
21. ATP-sensitive potassium channel modulation of the guinea pig ventricular action potential and contraction
22. ATP-regulated K+ channels in cardiac muscle
23. An experimental set-up for the blood perfused working isolated rat heart
24. Comparison of Tyrode and blood perfused working isolated rat hearts
25. The erythrocyte-perfused "working heart" model: Hemodynamic and metabolic performance in comparison to crystalloid perfused hearts
26. KATP channels in rat heart: Blockade of ischemic and acetylcholine-mediated preconditioning by glibenclamide
27. The involvement of ATP-sensitive potassium channels and adenosine in the regulation of coronary flow in the isolated perfused rat heart
28. Cardiovascular and biological effects of K+ channel openers, a class of drugs with vasorelaxant and cardioprotective properties
29. Involvement of ATP-sensitive potassium channels in preconditioning protection
30. Mechanisms of ATP conservation during ischemia in slow and fast heart rate hearts
31. Solid-phase extraction of 18beta-glycyrrhetinic acid from plasma and subsequent analysis by high-performance liquid chromatography
32. ATP-sensitive potassium channel is essential to maintain basal coronary vascular tone in vivo
33. Effect of glyburide on myocardial metabolism and fundion
34. Incomplete recovery of working heart function after twenty-four-hour preservation with a modified University of Wisconsin solution
35. Hyperpolarizing vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle
36. ATP-regulated potassium channel blocker, glibenclamide, uncouples mitochondria
37. Blockade of ATP-sensitive potassium channels increases infarct size but does not prevent preconditioning in rabbit hearts
38. Adenosine triphosphate-sensitive potassium channel blocking agent ameliorates, but the opening agent aggravates, ischemia/reperfusion-induced injury. Heart function studies in nonfibrillating isolated hearts